[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652611":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":16,"responsibleParty":58,"collaborators":60,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":70,"sex":76,"minAge":77,"maxAge":7,"enrollmentInfo":78,"targetDuration":7,"studyType":81,"phases":7,"briefSummary":82,"conditions":83,"keywords":85,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Foundation for the National Institutes of Health","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Steven Heymsfield, MD","CONTACT","650-688-4070","bodycompstudy@exponent.com",{"name":15,"role":11,"phone":12,"phoneExt":7,"email":13},"Ariel Dowling, PhD",[17,34,45],{"facility":18,"status":19,"city":20,"state":21,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Exponent Phoenix","RECRUITING","Phoenix","Arizona","85027","United States","US",{"type":26,"coordinates":27},"Point",[28,29],-112.07404,33.44838,{"lat":29,"lon":28},[32],{"name":33,"role":11,"phone":12,"phoneExt":7,"email":13},"Marysol Luna",{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":23,"countryCode":24,"cosmosGeoPoint":40,"geoPoint":44,"contacts":7},"Exponent Menlo Park","NOT_YET_RECRUITING","Menlo Park","California","94025",{"type":26,"coordinates":41},[42,43],-122.18219,37.45383,{"lat":43,"lon":42},{"facility":46,"status":19,"city":47,"state":48,"zip":49,"country":23,"countryCode":24,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"Exponent Boston","Boston","Massachusetts","01760",{"type":26,"coordinates":51},[52,53],-71.05977,42.35843,{"lat":53,"lon":52},[56],{"name":57,"role":11,"phone":12,"phoneExt":7,"email":13},"Ariel Dowling",{"type":59,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[61,64,66],{"name":62,"class":63},"Exponent, Inc.","UNKNOWN",{"name":65,"class":6},"Pennington Biomedical Research Center",{"name":67,"class":6},"Texas Tech University","100652611","redefining-evaluation-of-adiposity-and-leanness-broadening-objective-diagnostics-for-obesity-100652611",false,"NCT07776678","Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity","Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity (REAL-BODY)","REAL-BODY","Inclusion Criteria:\n\n* Being willing to provide written informed consent prior to participation Being willing to complete the study visits and comply with the study procedures\n* Being willing to travel to the various study locations for On-site, DXA, MRI, and Phlebotomy visits\n* Being willing to change into appropriate form-fitting clothing for 3DO assessments and\u002For appropriate gowns for DXA and MRI imaging\n* Must have a BMI within the range of 18.5 - 45 kg\u002Fm2\n* Being willing to refrain from all food, drink, and substances for 8 hours prior to the On-site visit(s) and phlebotomy visit\n* Being willing to refrain from all food, drink, and substances for 4 hours prior to the DXA and MRI scan visits\n* Being willing to refrain from any exercise or vigorous physical activity for 24 hours prior to all visits\n* Stable weight (no more than 5 kg change) for 3 months prior to screening\n* If recruited in the Phoenix, AZ area, participants must be willing to drive yourself to the Phoenix Office location for the On-site Visits 1 and 2 (if applicable) located at the Exponent Phoenix Office.\n\nExclusion Criteria:\n\n* Being pregnant or attempting to become pregnant\n* Having medical implants, such as a pacemaker or metal joint replacements, or other metal implants contraindicated for MRI\n* Cosmetic implants, such as breast implants\n* Having a height greater than DXA scanning limit (77 inches)\n* Having a body weight greater than indicated for the equipment (400 lbs)\n* Prior amputation or major body-altering surgery that could invalidate body composition estimates\n* Having claustrophobia or a history of claustrophobia\n* Known HIV infection\n* Known Lipodystrophy\n* Known hydration abnormality (e.g., significant edema, end-stage renal disease, end-stage liver disease)\n* Severe illness or life-threatening conditions such as end-stage kidney, liver, lung disease, NYHA III-IV heart failure, or active malignancy","ALL","18 Years",{"count":79,"type":80},300,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to evaluate body composition across a variety of medical, professional, and commercial devices, including: bioelectrical impedance analysis (BIA) devices, 3-dimensional optical imaging (3DO), manual anthropometry measurements, dual-energy X-ray absorptiometry (DXA), magnetic resonance imaging (MRI), and blood tests. The secondary study purpose is to compare body composition measurements from BIA devices, 3DO, and manual anthropometry measurements within a 1-week period for a subset of the study population.\n\nThe study plans to enroll 300 healthy (having no life-threatening conditions or diseases; male and female) participants, 18 years of age or older.",[84],"Obesity & Overweight",[86],"Body Composition","2026-08-17",{"date":89,"type":90},"2026-08-20","ACTUAL",{"date":92,"type":90},"2026-06-29",{"date":94,"type":80},"2027-03-30",{"name":5,"class":6},3]